CURLD (Curaleaf Holdings) Tariff Resilience Score: 5/10 (As of Jun. 24, 2026)


CURLD Curaleaf Holdings Inc CURLD
67 GF Score
Price $9.33
GF Value $8.11
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curaleaf Holdings Tariff Resilience Score?

Curaleaf Holdings CURLD -1.48% 67 Tariff Resilience Score is 5 as of Jun. 24, 2026. GuruFocus rates CURLD with a GF Score™ of 67/100 and a GF Value™ of $8.11 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,031 Drug Manufacturers companies, Curaleaf Holdings ranks better than 84.58% on this metric.

Curaleaf Holdings has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Curaleaf Holdings has Curaleaf faces moderate tariff risks due to its international cannabis operations. While it has diversified suppliers, regulatory complexities in different markets can amplify tariff impacts. Past tariffs have affected input costs, but pricing power offers some mitigation.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Curaleaf Holdings might have Average Resilient.

Curaleaf Holdings  (OTCPK:CURLD) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Curaleaf Holdings Tariff Resilience Score Related Terms

CURLD vs ZTS: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curaleaf Holdings Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's Tariff Resilience Score falls into.


CURLD
67GF Score
Curaleaf Holdings Inc CURLD
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Curaleaf Holdings (CURLD) has a Tariff Resilience Score of 5 as of Jun. 24, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Curaleaf Holdings ranks #159 out of 1031 companies in the Drug Manufacturers industry, placing it in the top 15.4%.
Is Curaleaf Holdings' Tariff Resilience Score too high?
Curaleaf Holdings' current Tariff Resilience Score is 5. Based on the distribution chart, Curaleaf Holdings ranks #159 out of 1031 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Curaleaf Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' Tariff Resilience Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Curaleaf Holdings ranks #159 out of 1031 companies for Tariff Resilience Score. This places Curaleaf Holdings in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Curaleaf Holdings's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (CURLD) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.11, compared to a current price of $9.33 — trading 15% above its estimated fair value. The current Tariff Resilience Score is 5. Curaleaf Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Curaleaf Holdings (CURLD), the current Tariff Resilience Score is 5 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (CURLD) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of $9.33 is trading 15% above its estimated GF Value™ of $8.11. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for CURLD:

  • Tariff Resilience Score: 5
  • GF Value™: $8.11 vs. price of $9.33 (15% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the CURLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curaleaf Holdings Business Description

Other Exchanges 2XW:GermanyCURA:Canada
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
67GF Score

Get the complete analysis for CURLD

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.33
Price
$8.11
GF Value